Prosecution Insights
Last updated: August 17, 2026

The Ohio State University

80 pending office actions • 46 art units • 73 examiners • 0 of 80 (0%) have an AI response strategy ready • 82 patents granted in the last 365 days

Portfolio Summary

80
Total Pending OAs
52
Non-Final OAs
24
Final Rejections
4
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 27 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

16
Overdue
0
Due this week
7
Due this month
1
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 27 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (16)Due ≤ 30 days (7)Due ≤ 60 days (1)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

40
Hard (50%)
33
Medium (41%)
5
Easy (6%)
2
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 + other7 (9%)
§103 only23 (29%)
§102 only4 (5%)
§112 only3 (4%)
Double-patenting only2 (2%)
Double-patenting + other6 (8%)
Multi-statute (no §101)33 (41%)
No statute on record2 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

46
Life Sciences
58% of docket
1
Information Tech
1% of docket
0
Communications
0% of docket
4
Semiconductors
5% of docket
17
Mechanical / Eng
21% of docket
12
Business / Other
15% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

800 h
Manual time on pending OAs
160 h
Time saved (low, 20%)
280 h
Time saved (mid, 35%)
7.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DABKOWSKI, ERINNE R 2 55.8% +69.0%
COFFA, SERGIO 2 61.1% +33.2%
LIEB, JEANETTE M 2 79.9% +17.2%
LAUER, CHRISTINA C 2 68.4% +15.1%
BLUMEL, BENJAMIN P 2 70.7% +30.6%
FAY, ZOHREH ALEMZADEH 2 52.0% -6.2%
VIVLEMORE, TRACY ANN 2 73.0% +6.7%
EZEWOKO, MICHAEL I 1 61.5% +51.2%
SHIRSAT, MARCELA 1 73.5% +19.7%
CARDIMINO, CHRISTOPHER RYAN 1 60.2% +23.8%

Hard Cases (40)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17583549 Composition for and Method of Improving Tissue Performance REYNOLDS, FRED H 72d overdue
18739226 CLINICAL DECISION SUPPORT SYSTEM AND METHOD HIGGS, STELLA EUN 71d overdue
17442471 ENGINEERED MRNA SEQUENCES AND USES THEREOF PENNINGTON, KATIE LEIGH 51d overdue
17790340 LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES WANG, CHANG YU 36d overdue
18908559 MULTIDIMENSIONAL OPTICAL TISSUE CLASSIFICATION AND DISPLAY LEE, ANDREW ELDRIDGE 9d overdue
18975570 SYSTEMS AND METHODS FOR PREDICTIVE HEART VALVE SIMULATION TALTY, MARIA CHRISTINA 3d overdue
17775236 METHODS AND COMPOSITIONS RELATING TO SELECTIVE INTRACELLULAR DELIVERY OF CD38 INHIBITORS VIVLEMORE, TRACY ANN 3d overdue
17608441 Reagents and Methods for Alzheimer's Disease and CoMorbidities Thereof PLAYER, ROBERT AUSTIN 1d overdue

Interview Candidates (13)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18644750 CYCLIC CELL-PENETRATING PEPTIDES WITH ONE OR MORE HYDROPHOBIC RESIDUES COFFA, SERGIO 12d
18962504 DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE OCCLUSION LAUER, CHRISTINA C 28d
18688553 DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE OCCLUSION LAUER, CHRISTINA C 28d
18166743 MANNOSE CONJUGATED CHITOSAN-BASED INFLUENZA NANOVACCINE FORMULATIONS AND USES THEREOF BLUMEL, BENJAMIN P 77d
19329417 CELL-PENETRATING PEPTIDE COMPOUNDS DABKOWSKI, ERINNE R 83d
19328400 METHOD AND SYSTEM FOR RISK STRATIFICATION AND CHEMOTHERAPY RESISTANCE PREDICTION IN PANCREATIC DUCTAL ADENOCARCINOMA EZEWOKO, MICHAEL I
19329427 CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS COFFA, SERGIO
19329431 INTRACELLULAR DELIVERY OF NUCLEIC ACIDS LIEB, JEANETTE M

Top Art Units

Art UnitApps
1654 5
1658 4
1636 3
1617 3
1675 3
3797 2
3771 2
2872 2
1671 2
1646 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19329417 CELL-PENETRATING PEPTIDE COMPOUNDS DABKOWSKI, ERINNE R 1654 §102§103§112DP Non-Final OA 83d Pending Sep 15, 2025
19328400 METHOD AND SYSTEM FOR RISK STRATIFICATION AND CHEMOTHERAPY RESISTANCE PREDICTION IN PANCREATIC DUCTAL ADENOCARCINOMA EZEWOKO, MICHAEL I 3682 §101§103 Non-Final OA Pending Sep 15, 2025
19329427 CYCLIC CELL-PENETRATING PEPTIDE COMPOUNDS COFFA, SERGIO 1658 §102DP Non-Final OA Pending Sep 15, 2025
19329431 INTRACELLULAR DELIVERY OF NUCLEIC ACIDS LIEB, JEANETTE M 1654 DP Non-Final OA Pending Sep 15, 2025
19275071 SYSTEMS AND METHODS FOR MECHANICAL DISPLACEMENT OF AN ESOPHAGUS SHIRSAT, MARCELA §102§103DP Non-Final OA Pending Jul 21, 2025
19207877 RANGE EXTENSION WITH OPTIMAL TRACTION CONTROL FOR MULTI E-AXLE BASED ELECTRIFIED VEHICLES CARDIMINO, CHRISTOPHER RYAN §103 Non-Final OA Pending May 14, 2025
19106073 SYSTEMS AND METHODS FOR COOPERATIVE NAVIGATION WITH AUTONOMOUS VEHICLES SMITH-STEWART, DEMETRA R 3661 §103 Non-Final OA Pending Feb 24, 2025
19102613 JIGS AND RELATED METHODS FOR GUIDING A CUTTING INSTRUMENT FOR CONTROLLED SURGICAL CUTTING OF A BODY PORTION OF A PATIENT YANG, ANDREW 3775 §102§103 Non-Final OA Pending Feb 10, 2025
18975570 SYSTEMS AND METHODS FOR PREDICTIVE HEART VALVE SIMULATION TALTY, MARIA CHRISTINA 3797 §103§112 Final Rejection 3d overdue Pending Dec 10, 2024
18962504 DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE OCCLUSION LAUER, CHRISTINA C 3771 §103§112 Non-Final OA 28d Pending Nov 27, 2024
18961890 METHOD FOR QUENCH DETECTION USING RF INTERROGATION OF COOLANT PERMITTIVITY LIU, KENDRICK X §103 Non-Final OA Pending Nov 27, 2024
18940720 SYSTEMS AND METHODS FOR IDENTIFYING SUBSURFACE HYDROGEN ACCUMULATION VARNDELL, ROSS E §101§103Other Non-Final OA Pending Nov 07, 2024
18863518 A MULTI-ADAPTABLE MELT ELECTROWRITING SYSTEM AND METHOD OF USING THE SAME BEHRENS JR., ANDRES E 1741 §102§103 Non-Final OA Pending Nov 06, 2024
18934431 COUPLED AUTONOMOUS PODS FOR SHARED MOBILITY RAMESH, KRISHNAN 3663 §103 Final Rejection 20d Pending Nov 01, 2024
18933216 AUTOMATED BIOREACTOR WITH FOAM COLLECTOR HINES, JANA A §103§112 Non-Final OA Pending Oct 31, 2024
18908559 MULTIDIMENSIONAL OPTICAL TISSUE CLASSIFICATION AND DISPLAY LEE, ANDREW ELDRIDGE 3684 §101§103Other Non-Final OA 9d overdue Pending Oct 07, 2024
18825158 APPARATUS AND METHOD FOR ENHANCED DETERMINATION OF OPTIMAL OPERATIONAL SEPARATION FOR COLLABORATIVE ROBOTIC SYSTEMS OH, HARRY Y 3657 Non-Final OA Pending Sep 05, 2024
18843934 WIND SPEED AND DIRECTION MEASUREMENT SYSTEM AND DEVICE TRAN, TRAN M. §103§112 Non-Final OA Pending Sep 04, 2024
18819397 X-RAY ASSISTIVE DEVICE FOR STANDARDIZING THE KNEE TEMPLATING BOOSALIS, FANI POLYZOS 2884 §103 Non-Final OA Pending Aug 29, 2024
18838519 Cerebrovascular-Tumor-On-A-Chip WILSON, MICHAEL C §102§103§112 Non-Final OA Pending Aug 14, 2024
18800711 RECURRENT QUANTUM PHOTONIC PROCESSOR AND METHODS BEATTY, COLLIN X 2872 §103 Non-Final OA Pending Aug 12, 2024
18730155 ALKANOLAMINE-CONTAINING MEMBRANES AND METHODS OF MAKING AND USING THEREOF LAWRENCE JR, FRANK M §102§103§112 Non-Final OA Pending Jul 18, 2024
18755185 CELL-PENETRATING PEPTIDE SEQUENCES DABKOWSKI, ERINNE R 1654 §102§103§112DP Non-Final OA Pending Jun 26, 2024
18739226 CLINICAL DECISION SUPPORT SYSTEM AND METHOD HIGGS, STELLA EUN 3681 §101§103 Non-Final OA 71d overdue Pending Jun 10, 2024
18716634 COMPOSITIONS AND METHODS FOR PRODUCTION AND USE OF A SCALABLE HUMAN CELL-DERIVED EXTRACELLULAR MATRIX SPENCE, JENNIFER SUZANNE §103§112 Non-Final OA Pending Jun 05, 2024
18710916 COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES AND INJURIES VIGIL, TORIANA NICHOLE 1612 §102§103§112 Non-Final OA 14d Pending May 16, 2024
18708499 COMPOSITIONS COMPRISING AMINO LIPID COMPOUNDS AND METHODS OF MAKING AND USE THEREOF SEAMAN, D MARGARET M §102 Non-Final OA Pending May 08, 2024
18704758 DESIGNER EXTRACELLULAR VESICLES FOR TARGETED DELIVERY TO SCHWANN CELLS OGUNBIYI, OLUWATOSIN A 1645 §102§103§112 Non-Final OA Pending Apr 25, 2024
18644750 CYCLIC CELL-PENETRATING PEPTIDES WITH ONE OR MORE HYDROPHOBIC RESIDUES COFFA, SERGIO 1658 §102 Final Rejection 12d Pending Apr 24, 2024
18635747 METHODS AND SYSTEMS FOR ALIGNING AN EYE FOR MAKING A DETERMINATION ABOUT THE EYE USING REMOTE OR TELEHEALTH PROCEDURES KAUFFMAN, RUBY LUCIA 2872 §103 Non-Final OA Pending Apr 15, 2024
18688553 DEVICES AND METHODS FOR LEFT ATRIAL APPENDAGE OCCLUSION LAUER, CHRISTINA C 3771 §102§103§112 Non-Final OA 28d Pending Mar 01, 2024
18419130 SYSTEMS AND METHODS FOR MEASURING AND AUDITING FAIRNESS TANK, ANDREW L §103 Non-Final OA Pending Jan 22, 2024
18579084 COMPOSITIONS AND TREATMENTS FOR CORONAVIRUS INFECTIONS RAMADAN, OMAR §101§102§112 Non-Final OA Pending Jan 12, 2024
18541399 Systems and Methods for a Radio Interface Layer Defense MAGLOIRE, VLADIMIR 3648 §102§103 Non-Final OA 61d Pending Dec 15, 2023
18541815 BICYCLIC PEPTIDYL INHIBITOR OF TUMOR NECROSIS FACTOR-ALPHA VARADARAJ, ARCHANA 1658 DP Non-Final OA Pending Dec 15, 2023
18524669 WICKING MATERIALS TATESURE, VINCENT 1786 §103 Final Rejection Pending Nov 30, 2023
18516449 Systems and Methods for Monitoring and Detection of Anomalous Activity in Software-Defined Radio Access Networks EBRAHIM, ANEZ C 2467 §103 Final Rejection Pending Nov 21, 2023
18560422 IN SITU DAMAGE FREE ETCHING OF Ga2O3 USING Ga FLUX FOR FABRICATING HIGH ASPECT RATIO 3D STRUCTURES ADHIKARI DAWADI, BIPANA 2898 §112 Final Rejection Pending Nov 13, 2023
18501323 COMBINATIONS FOR TREATMENT OF CANCERS RESISTANT TO EGFR-TARGETED THERAPIES ULLMAN, AARON RAFANAN 1628 §103 Final Rejection Pending Nov 03, 2023
18557218 LIPID NANOMATERIALS AND USES THEREOF ZAHORIK, AMANDA MARY 1636 §102 Non-Final OA Pending Oct 25, 2023
18284743 METHODS OF IMPROVING ELECTRODE STABILITY IN HIGH VOLTAGE ENERGY STORAGE DEVICES D'ANIELLO, NICHOLAS P 1723 §102§103 Non-Final OA Pending Sep 28, 2023
18547976 EXTRACELLULAR VESICLE-BASED NANOCARRIERS BLUMEL, BENJAMIN P 1671 §103 Non-Final OA Pending Aug 25, 2023
18447109 METHODS AND COMPOSITIONS RELATED TO ANTIBODY FRAGMENTS THAT BIND TO TUMOR-ASSOCIATED GLYCOPROTEIN 72 (TAG-72) SANG, HONG 1646 §103§112Other Non-Final OA 56d Pending Aug 09, 2023
18276397 SMALL MOLECULE INHIBITORS OF CD38 AS IMMUNOSUPPRESSANTS SCHACHERMEYER, SAMANTHA LYNN 1693 §103 Final Rejection 80d overdue Pending Aug 08, 2023
18274964 POLYMERIC MICROPARTICLES, COMPOSITIONS, AND METHODS FOR SUSTAINED RELEASE OF AN ACTIVE AGENT SUSCEPTIBLE TO ABUSE PEEBLES, KATHERINE 1617 §103§112 Final Rejection Pending Jul 28, 2023
18274082 MULTIPLEXED MICROFLUIDIC FORCE SPECTROSCOPY ON-A-CHIP HERBERT, MADISON TAYLOR 1681 §103 Non-Final OA Pending Jul 25, 2023
18274075 TARGETED RETROVIRAL INTEGRATION FOR TREATMENT OF GENETIC DISORDERS WARD, AARON DUREL 1636 §102§103§112 Non-Final OA Pending Jul 25, 2023
18350219 RECOMBINANT EGFL7, EGFL7 ANTIBODIES, AND USES THEREOF BUCCINI, MICHELLE CALLAHAN 1675 §103§112 Non-Final OA Pending Jul 11, 2023
18270286 ELECTROMAGNETIC IMPLANT FOR TREATMENT OF SOLID CANCERS CASLER, BRIAN L 3791 §103§112 Final Rejection Pending Jun 29, 2023
18036825 METHODS AND COMPOSITIONS FOR CANCER THERAPY FAY, ZOHREH ALEMZADEH 1617 §103§112 Non-Final OA Pending May 12, 2023
18307512 SYSTEMS AND METHODS TO MEASURE AND IMPROVE EYE MOVEMENTS AND FIXATION MERRIAM, AARON ROGERS 3791 §103§112 Final Rejection Pending Apr 26, 2023
18027589 METHODS, COMPOSITIONS, AND KITS FOR DETECTING AND MEASURING ENDOTHELIAL INJURY IN NORMAL AND DISEASED HUMAN CENTRAL NERVOUS SYSTEM (CNS) CHERNYSHEV, OLGA N 1675 §101§112 Non-Final OA Pending Mar 21, 2023
18024806 NOVEL ENGINEERED CAPSID SEROTYPE OF RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR WITH ENHANCED TRANSDUCTION EFFICIENCY AND WIDESPREAD DISTRIBUTION IN THE BRAIN TINSLEY, BRENDAN THOMAS 1634 §102§103§112Other Non-Final OA Pending Mar 06, 2023
18114781 SOFT ROBOTIC GRIPPER WITH A VARIABLE STIFFNESS ENABLED BY POSITIVE PRESSURE LAYER JAMMING GARFT, CHRISTOPHER 3632 §103 Non-Final OA 9d overdue Pending Feb 27, 2023
18022804 CATALYSTS AND METHODS OF MAKING AND USE THEREOF LACLAIR, LOGAN EDWARD 1732 §102§112 Non-Final OA Pending Feb 23, 2023
18166743 MANNOSE CONJUGATED CHITOSAN-BASED INFLUENZA NANOVACCINE FORMULATIONS AND USES THEREOF BLUMEL, BENJAMIN P 1671 §103 Final Rejection 77d Pending Feb 09, 2023
18018707 NANOSTRUCTURED ELECTRODES AND METHODS OF MAKING AND USE THEREOF CONTRERAS, CIEL P 1794 §103§112 Non-Final OA Pending Jan 30, 2023
18011399 REDOX-RESPONSIVE NANOPARTICLE COMPOSITIONS FOR OCULAR DELIVERY OF THERAPEUTICS FAY, ZOHREH ALEMZADEH 1617 §103 Final Rejection Pending Dec 19, 2022
18007918 NANOFIBER CARDIAC PATCH AND METHODS OF USE THEREOF TYSON, MELANIE RUANO 3774 §103 Non-Final OA Pending Dec 02, 2022
17923829 SCALABLE SYNTHESIS OF SEMI-CONDUCTING CHEVREL PHASE COMPOUNDS VIA SELFPROPAGATING HIGH TEMPERATURE SYNTHESIS SMARI, ABDUL-RAHMAN YUSUF WALEED 1736 §103 Non-Final OA 26d Pending Nov 07, 2022
17922472 METHODS AND COMPOSITIONS FOR ENHANCING STABILITY AND SOLUBILITY OF SPLIT-INTEINS LIEB, JEANETTE M 1654 §102§103DP Non-Final OA Pending Oct 31, 2022
17918051 ELECTROCEUTICAL DRESSING FOR WOUND CARE TEHRANI, DANIEL 3792 §103§112 Non-Final OA Pending Oct 10, 2022
17955413 PREBIOTIC FORMULATIONS AFREMOVA, VERA 1653 §103 Final Rejection 15d overdue Pending Sep 28, 2022
17790340 LOOPED PROTEINS COMPRISING CELL PENETRATING PEPTIDES WANG, CHANG YU 1675 §102§103§112Other Final Rejection 36d overdue Pending Jun 30, 2022
17778765 IMMUNOMAGNETIC SEQUENTIAL ULTRAFILTRATION PLATFORM FOR ENRICHMENT AND PURIFICATION OF EXTRACELLULAR VESICLES FROM BIOFLUIDS MARTIN, PAUL C 1653 §103 Final Rejection 2d overdue Pending May 20, 2022
17745621 DUAL ANDROGEN RECEPTOR/AKR1C3 INHIBITORS SEITZ, ANTHONY JOSEPH 1629 §102 Final Rejection 60d overdue Pending May 16, 2022
17775236 METHODS AND COMPOSITIONS RELATING TO SELECTIVE INTRACELLULAR DELIVERY OF CD38 INHIBITORS VIVLEMORE, TRACY ANN 1638 §103§112 Final Rejection 3d overdue Pending May 06, 2022
17638600 HEMOGLOBIN-BASED NANOPARTICLES FOR OXYGEN DELIVERY HELLMAN, KRISTINA M 1654 §112 Final Rejection 36d overdue Pending Feb 25, 2022
17583549 Composition for and Method of Improving Tissue Performance REYNOLDS, FRED H 1658 §102§103§112Other Non-Final OA 72d overdue Pending Jan 25, 2022
17622048 NEURODEGENERATIVE DISEASE THERAPIES UTILIZING THE SKIN-BRAIN AXIS HUDSON, AMY ROSE 1636 §102§103§112 Non-Final OA 29d Pending Dec 22, 2021
17612779 TASTE MODULATING COMPOUNDS AND METHODS OF IMPROVING THE QUALITY OF FOODS AND BEVERAGES KERSHAW, KELLY P 1791 §103 Final Rejection Pending Nov 19, 2021
17608441 Reagents and Methods for Alzheimer's Disease and CoMorbidities Thereof PLAYER, ROBERT AUSTIN 1686 §101§102§112Other Final Rejection 1d overdue Pending Nov 02, 2021
17442471 ENGINEERED MRNA SEQUENCES AND USES THEREOF PENNINGTON, KATIE LEIGH 1634 §103§112 Non-Final OA 51d overdue Pending Sep 23, 2021
17284284 EXTRACELLULAR VESICLES FOR TARGETED THERAPIES AGAINST MYELOID-DERIVED SUPPRESSOR CELLS GUSTILO, ESTELLA M 1646 §112 Final Rejection Pending Apr 09, 2021
17265086 ANODES AND METHODS OF MAKING AND USING THEREOF DOVE, TRACY MAE 1725 Non-Final OA 8d overdue Pending Feb 01, 2021
17262989 DERIVATIVES OF PAPAVERINE THAT ARE EFFECTIVE HYPOXIC TUMOR RADIOSENSITIZERS ELENISTE, PIERRE PAUL 1622 §102§103 Non-Final OA Pending Jan 25, 2021
17102291 Intrathecal Delivery of Recombinant Adeno-Associated Virus 9 LEONARD, ARTHUR S 1631 §103Other Final Rejection Pending Nov 23, 2020
16598833 COMPOSITION FOR AND METHOD OF FACILITATING CORNEAL TISSUE REPAIR VIVLEMORE, TRACY ANN 1638 §103§112 Non-Final OA Pending Oct 10, 2019
16321777 EXPRESSION OF PTEN-LONG WITH ONCOLYTIC VIRUSES QIAN, CELINE X 1637 §103DP Final Rejection 31d overdue Pending Jan 29, 2019
18636895 METHOD FOR DETERMINING A FIRST MOTION PHASE, METHOD FOR CORRECTING A TRIGGERING, MAGNETIC RESONANCE DEVICE, COMPUTER PROGRAM PRODUCT AND A COMPUTER-READABLE STORAGE MEDIUM COOK, CHRISTOPHER L 3797 §102§103 Non-Final OA Pending Apr 16, 2024

Managing The Ohio State University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month